Reduced Anticoagulation Targets in Extracorporeal life support
- Conditions
- Heart or lungfailure
- Registration Number
- NL-OMON22774
- Lead Sponsor
- niversity Medical Center Groningen (UMCG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 330
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•ECLS treatment during the study period in one the participating centers
•(deferred) informed consent
•Age above 18
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
•Patients in whom the ECLS is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery
•No (deferred) informed consent
•Vital indication for anticoagulation (e.g. mechanic mitral valve, pulmonary embolism)
•Heparin induced thrombocytopenia (HIT)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method